Just the same
Some individuals may not benefit from supplements
They are not recommended for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

Key Takeaways A Retatrutide titration chart outlines the general stages of dose progression, not a fixed schedule that applies identically to every patient Providers use these charts as a reference framework, adjusting timing and increments based on each patients tolerability Retatrutide remains an investigational compound, so titration pacing is always determined through provider judgment rather than a standardized public protocol Reconstitution and specific measurement instructions are handled directly between a patient and their prescribing provider, not through self-calculated amounts Patients tend to have a smoother experience when they follow their providers individualized pace rather than a generic chart found online What A Typical Retatrutide Titration Chart Looks Like Most titration charts for investigational compounds like Retatrutide are organized around general stages rather than exact dates, since the actual pace depends entirely on how a patient responds at each step

In the ELLIPSE trial, adverse reactions that occurred in more than 5% of the child or adolescent trial participants included headache, nasopharyngitis, dizziness, gastroenteritis, upper respiratory tract infection, rash, pyrexia, and decreased appetite.